| Financial Year |
March 31 2023 |
| Monetary Funds |
2,776,019,377.52 |
| Held-for-trading Financial Assets |
30,085,808.22 |
| Notes Receivable |
17,308,881.71 |
| Accounts Receivable |
151,436,516.71 |
| Advances to Suppliers |
275,537,727.46 |
| Other Receivables |
17,116,047.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
780,093,674.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
263,850,306.31 |
| Total Current Assets |
4,311,448,340.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,630,946.47 |
| Investment Properties |
323,994.67 |
| Fixed Assetes |
7,570,625,009.92 |
| Under-construction Projects |
1,223,443,278.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,192,027,812.71 |
| R&D expenses |
-- |
| Goodwill |
71,151,037.39 |
| Long-Term Deferred and Prepaid Expenses |
24,156,015.82 |
| Deferred Income Tax Assets |
145,605,798.61 |
| Other Non-Current Assets |
241,753,258.58 |
| Sub-Total of Non-Current Assets |
10,502,449,215.17 |
| Total Assets |
14,813,897,555.53 |
| Short-Term Loans |
2,348,180,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
348,338,514.72 |
| Accounts Payable |
462,988,676.52 |
| Accounts Received In Advance |
24,495,694.47 |
| Employee Compensation Payable |
40,899,980.63 |
| Taxes Payable |
12,851,681.29 |
| Interest Payable |
3,826,112.66 |
| Dividend Payable |
-- |
| Other payables |
61,570,672.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
409,671,822.51 |
| Other Current Liabilities |
8,125,658.36 |
| Sub-Total of Current Liabilities |
3,779,670,107.87 |
| Long-term Loans |
2,965,842,762.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
207,642,039.72 |
| Other Non-Current Liabilities |
562,500.00 |
| Sub-Total of Non-Current Liabilities |
3,505,452,689.64 |
| Total Liabilities |
7,285,122,797.51 |
| Paid-In Capital(Or Share Stock) |
1,335,568,000.00 |
| Capital Surplus |
2,721,632,648.82 |
| Surplus Reserve |
325,989,625.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,651,886,193.25 |
| Minority Stockholder's Interest |
439,783,017.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,088,991,740.67 |
| Owner's Equity（Stockholder's Equity） |
7,528,774,758.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,813,897,555.53 |
